Effects of prostaglandin and clomiphene citrate on pregnancy outcome
Phase 3
- Conditions
- Infertility.Female infertility associated with male factorsN97.4
- Registration Number
- IRCT20090912002445N8
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 106
Inclusion Criteria
Patients with primary and secondary infertility
Age between 18 and 45 years
Candidates for mild ovarian stimulation and intrauterine insemination (IUI)
Exclusion Criteria
Sensitivity to prostaglandins
Medical history of hepatic or renal diseases
Polycystic ovarian syndrome (PCOS)
Not having consent for inclusion in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pregnancy Rate. Timepoint: 14 weeks. Method of measurement: Chemical Beta-HCG test.
- Secondary Outcome Measures
Name Time Method umber of Dominant Follicle. Timepoint: 14 days. Method of measurement: Transvaginal Sonography.;Endometrial thinkness. Timepoint: 14 days. Method of measurement: Transvaginal sonography.;Side effects. Timepoint: 1 month. Method of measurement: Adverse effects form.